Pharmacy CE & CPE Events Calendar

An American Journal of Managed Care Forum: Advances in Prostate Cancer - An Evidence-based Review for Managed Care Professionals

Advances and Best Practices for Managed Care Pharmacists in the Treatment of Metastatic Head and Neck Squamous Cell Carcinoma: Updates From the ESMO Congress 2022

Management of Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI): Pharmacist-Led Strategies for Optimizing Clinical and Patient Outcomes

2022 ASHP Midyear Clinical Meeting & Exhibition

Mandalay Bay Convention Center

Clinical Conversations: Novel Approaches for the Treatment of cGVHD With Newly Approved and Emerging Therapies

Tumor-Infiltrating Lymphocytes: Infiltrating the Boundaries of Cancer Care in Solid Tumors Through a Managed Care Lens

Implementing New Therapy Options for Vulvovaginal Candidiasis Into Clinical Practice: The Role of the Pharmacist

A Pharmacist’s Guide to the Use of Targeted Therapy for HER2-Positive Breast Cancer

2022 ASH Annual Meeting Coverage—Recent Developments in Diffuse Large B-Cell Lymphoma: Insights and Application for Managed Care

Making the Most of Anti-Androgen Therapies in Prostate Cancer Through Pharmacist Interventions

Hidradenitis Suppurativa: Pharmacist Considerations for the Emerging Treatment Options

A Focus on New Therapies for ADHD: Expanding Treatment Options for Patients

Advances in High-Risk Myelodysplastic Syndromes: Insights and Application for Managed Care With ASH Annual Meeting Coverage

Optimizing the Use of Targeted Therapies for the Treatment of ROS1-Rearranged and KRAS-Mutant Non−Small Cell Lung Cancer

2022 ASH Annual Meeting Coverage—Recent Developments in Diffuse Large B-Cell Lymphoma: Insights and Application for Managed Care

JAK Inhibitors and the Evolving Treatment Landscape in Atopic Dermatitis and Alopecia Areata

Updates in the Treatment of Steroid-Refractory Chronic Graft-versus-Host Disease and the Role of the Oncology Pharmacist

Exploring Treatment Options in Fabry Disease to Address Management Gaps and Improve Patient Outcomes

Optimizing Administration of CAR T-Cell Therapy in Multiple Myeloma Through Pharmacist Interventions

Innovations in Cancer Care: Examining the Emerging Role of Bispecific Antibodies in Relapsed/Refractory Lymphoma and Multiple Myeloma

Managed Care Considerations and Implementation Strategies for Biosimilars in Oncology